Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction

Atherosclerosis

Volumn 222, Issue 2, 2012, Pages 464-467

  Kim, Jinkwon ^a   Song, Tae Jin ^a   Park, Ji Hye ^a   Lee, Hye Sun ^a   Nam, Chung Mo ^a   Nam, Hyo Suk ^a   Kim, Young Dae ^a   Heo, Ji Hoe ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

Leukocyte; Lymphocyte; Stroke; White blood cell

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE BRAIN INFARCTION; ACUTE DISEASE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAIN INFARCTION; CELL TYPE; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS;

AGED; CEREBRAL INFARCTION; DISABILITY EVALUATION; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; LINEAR MODELS; LOGISTIC MODELS; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUTROPHILS; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECOVERY OF FUNCTION; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84862818964     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.02.042     Document Type: Article

References (15)

1. Niemetz J., Fani K. Thrombogenic activity of leukocytes. Blood 1973, 42:47-59.
2. Ross R. Atherosclerosis-an inflammatory disease. New England Journal of Medicine 1999, 340:115-126.
3. Macrez R., Ali C., Toutirais O., et al. Stroke and the immune system: from pathophysiology to new therapeutic strategies. Lancet Neurology 2011, 10:471-480.
4. Lee B.I., Nam H.S., Heo J.H., et al. Yonsei Stroke Registry. Analysis of 1,000 patients with acute cerebral infarctions. Cerebrovascular Diseases 2001, 12:145-151.
5. Adams H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993, 24:35-41.
6. Emerich D.F., Dean R.L., Bartus R.T. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?. Experimental Neurology 2002, 173:168-181.
7. Price C.J., Menon D.K., Peters A.M., et al. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke 2004, 35:1659-1664.
8. Investigators E.A.S.T. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 2001, 57:1428-1434.
9. Acanfora D., Gheorghiade M., Trojano L., et al. Relative lymphocyte count: a prognostic indicator of mortality in elderly patients with congestive heart failure. American Heart Journal 2001, 142:167-173.
10. Ommen S.R., Gibbons R.J., Hodge D.O., et al. Usefulness of the lymphocyte concentration as a prognostic marker in coronary artery disease. The American Journal of Cardiology 1997, 79:812-814.
11. Núñez J., Sanchis J., Bodí V., et al. Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels. Atherosclerosis 2009, 206:251-257.
12. Horne B.D., Anderson J.L., John J.M., et al. Which white blood cell subtypes predict increased cardiovascular risk?. Journal of the American College of Cardiology 2005, 45:1638-1643.
13. Park B.-J., Shim J.-Y., Lee H.-R., et al. Relationship of neutrophil-lymphocyte ratio with arterial stiffness and coronary calcium score. Clinica Chimica Acta 2011, 1-5.
14. Urra X., Cervera A., Villamor N., et al. Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 2009, 158:1174-1183.
15. Baird A.E. The forgotten lymphocyte: immunity and stroke. Circulation 2006, 113:2035-2036.